Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • McDonald Emiantor : A rapper, An Entrepreneur or both? Business
  • AVG Logistics Delivers Impressive 66% PBT Growth in Q4 FY25 Business
  • ​​​​Indian society’s stereotypes about Married women have been broken by Pooja Parmeshwar, who won Mrs. India Queen Lifestyle
  • Zapllo Technologies Launches Task Delegation App Business
  • Orenburg State Medical University Issues Warning About Fake Documents Circulating in India Education
  • Siddharth Rajsekar Revives the Spirit of Nalanda with the Quantum Club Retreat 2024 at Mahabalipuram Education
  • Events like TEDx ought to be supported for city’s youth: Ketan Mohitkar Business
  • P.C. Chandra Jewellers Unveils ‘Swarnaraga: Craftsmanship Composed Like a Timeless Raga’ Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Who Moved My Protein? Launches With a Call for Transparency and Ethics in the Protein Industry Business
  • APHA Collaborates With Yumzy to Serve Their Customers Directly Business
  • Guide to Paying UPPCL Electricity Bills Online via ICICI Bank Net Banking and iMobile App Business
  • Jabra Evolve2 65 Flex review – A Must-Have for Modern Workspaces Business
  • Chamunda Electrical Limited Raises Rs 411.00 Lakhs from Anchor Investors Ahead of its IPO Business
  • XIPHIAS Immigration – The Global Leader In Residence and Citizenship by Skill Migration Business

Recent Posts

  • MGM Maran: Orchestrating Global Growth for the MGM Group with Recent China Visit
  • Zero NPA. Zero Shortcuts. Zero Compromise. The Best of 96 Years
  • The Quiet Glamour of Hayaam by Zam Zam Perfumers
  • PSS Legal Appoints Rakhi Kapoor As its Chief Wellness Officer, Marking A First For India’s Corporate Legal Sector
  • A Pharmaceutical Injectable Manufacturing Company, opens its IPO on 21st May, 2026.

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Actress Sezal Sharma Graces the Cannes 2025 Red Carpet with Timeless Glamour Entertainment
  • OTT platform ‘Mask TV’ Unlocking Happiness with an Original Series “Mission 70” Business
  • Sathlokhar Synergys E&C Global Limited Strengthens industry positioning through Record Order Wins, Diversified Client Portfolio and Credit Rating Upgrade Business
  • CecureUs Secure and Inclusive Workplace Awards 2023-2024 Lifestyle
  • Mehak Dhingra Champions Self-Management Education in Type 1 Diabetes, Bridging Critical Gaps in Indian Healthcare Lifestyle
  • Renowned Plastic Surgeon Dr. Viral Desai honoured at the IMCAS WORLD CONGRESS PARIS 2024 Health
  • Renowned I.T. Architect Mathangi Shankar made her Debut in Bharatanatyam Arenghetram Lifestyle
  • Krishna Shalby Hospital Strengthens Cancer Care in Ahmedabad with Launch of ‘Elekta Infinity’ Radiation System Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme